Correlation Between Apexigen and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Apexigen and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apexigen and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apexigen and Altamira Therapeutics, you can compare the effects of market volatilities on Apexigen and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apexigen with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apexigen and Altamira Therapeutics.
Diversification Opportunities for Apexigen and Altamira Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Apexigen and Altamira is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Apexigen and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Apexigen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apexigen are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Apexigen i.e., Apexigen and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Apexigen and Altamira Therapeutics
If you would invest (100.00) in Altamira Therapeutics on December 27, 2024 and sell it today you would earn a total of 100.00 from holding Altamira Therapeutics or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Apexigen vs. Altamira Therapeutics
Performance |
Timeline |
Apexigen |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Altamira Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Apexigen and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Apexigen and Altamira Therapeutics
The main advantage of trading using opposite Apexigen and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apexigen position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.Apexigen vs. Leap Therapeutics | Apexigen vs. Zura Bio Limited | Apexigen vs. X4 Pharmaceuticals | Apexigen vs. Phio Pharmaceuticals Corp |
Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamental Analysis View fundamental data based on most recent published financial statements |